You are currently viewing a new version of our website. To view the old version click .

Novel Insights into Depression Research: Neurobiology, Models, Biomarkers and Therapies

This special issue belongs to the section “Neurobiology and Clinical Neuroscience“.

Special Issue Information

Dear Colleagues,

Depression remains the leading cause of disability worldwide, yet its pathophysiology is still incompletely understood, hampering its diagnosis and therapeutic success. This Special Issue, “Novel Insights into Depression Research: Neurobiology, Models, Biomarkers and Therapies,” highlights breakthroughs that are rapidly redefining this field. We welcome original articles and authoritative reviews that elucidate novel synaptic, immune or gut–brain mechanisms; validate next-generation animal, organoid or in silico models; and identify robust genomic, proteomic or digital biomarkers capable of predicting depression onset, trajectory or treatment response. Contributions showcasing rapid-acting antidepressants and innovative neuromodulation protocols are also welcome, as they further bridge mechanistic insights and clinical practice.

We invite researchers to contribute high-quality original research and review articles to this Special Issue that advance our understanding of depression and shape the future of more effective, personalized treatments. We hope that this Special Issue will provide a platform to inform new breakthroughs in this field.

Prof. Dr. Adela Magdalena Ciobanu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • depression
  • neurobiology
  • biomarkers
  • experimental models
  • antidepressant therapies
  • personalized medicine
  • treatment resistance
  • pharmacology
  • psychiatric disorders

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059